{"title":"Olanzapine: efficacy in treating the positive and negative symptoms of schizophrenia.","authors":"R Gray","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In the second of this series of updates on recent advances in medication, RICHARD GRAY summarises trials into the novel antipsychotic olanzapine, which has been shown to compare well to haloperidol, and is now widely used for treating schizophrenia and related psychoses.</p>","PeriodicalId":79511,"journal":{"name":"Mental health care","volume":"1 6","pages":"193-4"},"PeriodicalIF":0.0000,"publicationDate":"1998-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mental health care","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In the second of this series of updates on recent advances in medication, RICHARD GRAY summarises trials into the novel antipsychotic olanzapine, which has been shown to compare well to haloperidol, and is now widely used for treating schizophrenia and related psychoses.